Key Takeaways Spironolactone is effective for both premenopausal and postmenopausal women Finasteride is primarily used for ...
Lancet Oncol 8: 21–25 Finasteride, a type 2 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH) at 5 mg daily, and male-pattern alopecia at 1 mg daily. The 5 mg regimen ...
Therefore, we randomly assigned 14 hirsute women in a 2:1 ratio to 1 of 2 treatment arms: 1) finasteride (F) treatment (n = 9; 5 mg, orally, daily), or 2) spironolactone (S) treatment (n = 5 ...
Patients received ER alfuzosin 5 mg twice daily, finasteride 5 mg daily, or both drugs for six months. Alfuzosin alone and alfuzosin-finasteride combination therapy significantly improved symptoms ...
All participants received 5 mg/day finasteride and were randomly assigned to receive either counseling on the potential sexual adverse effects of the drug or no such counseling. Using patients ...